Literature DB >> 27189097

[Safety and efficacy of ketamine for pain relief].

Marieke Niesters1, Albert Dahan, Maarten van Kleef.   

Abstract

Intravenous ketamine treatment is frequently used for the management of chronic pain, especially in those patients who do not benefit from other therapies. In this commentary we discuss the efficacy of ketamine for relief of chronic pain and ketamine's safety profile. A review of the literature indicates that only a few studies show that intravenous ketamine has analgesic effects that persist beyond the infusion period, an effect that occurs in about two-thirds of patients. Ketamine has multiple safety issues, ranging from psychotomimetic and schizotypal symptoms, sympathetic stimulation, tachycardia and hypertension, and damage to the liver and the urogenital tract. Damage to the urogenital tract seems to be restricted to individuals who chronically abuse ketamine. We indicate the need for large randomized trials in which ketamine is compared with an 'active' placebo.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27189097

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  1 in total

1.  Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series.

Authors:  Clinton Lauritsen; Santiago Mazuera; Richard B Lipton; Sait Ashina
Journal:  J Headache Pain       Date:  2016-11-22       Impact factor: 7.277

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.